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Prescription drug abuse is defined as the use of prescription opioids without a prescription or use
only for the experience or feeling they cause (Substance Abuse and Mental Health Services
Administration, 2014). Prescription drug abuse/misuse (PDA/M), in particular the abuse of
prescription opioid (PO) medications, has reached epidemic proportions in the United States
(Centers for Disease Control and Prevention [CDC], 2011). Substance Abuse and Mental Health
Services Administration (2014) data indicate that there are over 4.5 million past month nonmedical users of prescription opioid medications in the U.S. alone.
Overdose death has quadrupled since 1999, much of which is a result of prescription drug abuse
(Chen, Hedegaard, & Warner, 2013). On average 83 opioid medications were prescribed per 100
people in the U.S. in 2012 (Paulozzi, Mack, & Hockenberry, 2014). The state of Tennessee is
disproportionately struggling with the prescription drug abuse epidemic and has the second
highest oral (PO) prescribing rate per capita (Paulozzi et al.). In addition, Tennessee experienced
a 250% increase in PO-related overdose deaths from 2001 to 2010, accounting for 7% of
prescription drug overdose deaths nationally despite comprising only 2.3% of the nation’s
population (CDC, 2011; Tennessee Department of Health Safety Subcabinet Working Group,
2012).
Neonatal Abstinence Syndrome (NAS), a condition resulting from intrauterine exposure to
maternal prescription drugs, has also reached epidemic proportions in the Northeast region of
Tennessee; in particular, this region accounts for a disproportionate incidence of babies born
with NAS statewide with a rate of 41.6 per 1,000 live births versus the state rate of 11.6 per
1,000 live births (Tennessee Department of Health, Division of Family Health and Wellness,
2013). The geographic placement of East Tennessee State University (ETSU) and its Academic
Health Sciences Center (AHSC) in this high PDA/M prevalence location allowed for ready
engagement on the problem.
ETSU is a regional public university located in this Northeast part of the state with the highest
prevalence of PO prescribing, misuse and its resultant outcomes, addiction, overdose and NAS.
ETSU is a Carnegie-designated Doctoral Research University with a comprehensive AHSC that
is a member of the Association of Academic Health Centers (AAHC).
In the past few years, a team of interprofessional scientists at ETSU has come together to address
the problem of prescription drug abuse. Since then, they have been successful in grant writing,
publication, public education, and are attempting to impact policy through their work. The
purpose of this manuscript is to describe the experience of creating and maintaining this highly
interprofessional research team, with the aim of encouraging purposeful cultivation of similar
interprofessional teams to address significant public health needs.

Working Group History
In spring 2012, three ETSU researchers, four university administrators, and one community
health care professional met to discuss the PDA/M problem and the role ETSU could play in
addressing community and regional needs. Challenged and energized by the encounter, the
researchers resolved to meet frequently to identify priority areas for research activities. From the
first meeting, the group knew that the complexity of the problem would require interprofessional
collaboration, community partnerships, teamwork, and an integrated training model that included

Published by Digital Commons @ East Tennessee State University, 2016

1

International Journal of Health Sciences Education, Vol. 3 [2016], Iss. 2, Art. 5

faculty and student interaction. The group sought out other individuals who shared interest in
PDA/M, including other ETSU faculty and staff, and anti-drug coalitions in the region. Monthly
meetings were scheduled and held on ETSU’s campus. By the end of 2012, the Working Group
invitation list grew to more than 20 scholars, clinicians, students and community partners
working in prevention, treatment, or other related settings. In the first year, roughly 7-10
members would attend the meetings. By the end of 2012, the list had grown to more than 90,
with approximately 30-35 members attending each meeting. The group developed organically. A
formal systematic approach to engaging new members was never employed. Members learned of
the group and joined based on their personal or professional interest in the problem, and those
who stay engaged were frequently mapped onto new research proposals or community
interventions. The Working Group continues to grow and sustains a high level of productivity
due in part to the informal nature of the monthly meetings that allow scholars, students, and
community members to brainstorm new research questions, discuss community issues, and
implement effective interventions simultaneously. In 2015 the group began alternating monthly
meetings between the university campus and partner agencies settings in order to maintain the
vital connection to the community. Figure 1 below shows the diversity of the group by primary
discipline and represents the total number of members in the PDAM Working Group by
discipline.
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Figure 1. Prescription Drug Abuse Working Group Membership
The PDA/M Working Group continues to meet monthly and is now comprised of a remarkable
list of gifted scholars and invested community partners. The list includes nationally known
speakers, advocates, public health practice leaders, community residents, former addicts and
scholars.

https://dc.etsu.edu/ijhse/vol3/iss2/5

2

Pack et al.: The ETSU Prescription Drug Abuse/Misuse Working Group

The meetings usually open with a partner update that takes half or more of the meeting time. By
beginning with this step the group provides an informal milieu that allows for connections to be
made between projects and partners. Dozens of new activities and projects have been initiated in
these meetings and the consistency of the meeting staff and time has provided the mechanism to
keep track of projects and updates.
Early on, the group identified the need for consistent research, education and practice on the
topic and set a goal to gather the internal and external resources to ultimately create a Center for
Prescription Drug Abuse Prevention and Treatment at ETSU. Recognizing the need for
consistent financial support the group immediately began searching for a federally funded
mechanism for infrastructure development.
The concerted effort of this group resulted in the formal submission of a large-scale National
Institute on Drug Abuse (NIDA) proposal that was funded on the first attempt in 2013. The grant
established the ETSU Diversity-promoting Institutions Drug Abuse Research Program (ETSUDIDARP) called Interprofessional Communication to Reduce Prescription Drug Abuse in
Appalachia. The program supports training and mentorship of students and faculty while
executing three prescription drug abuse research projects. The projects are focused on
interprofessional communication by prescribers, dispensers and patients to reduce PDA/M and a
focused effort to increase the volume of prescription drugs that are taken to pill “drop-boxes” for
incineration by law enforcement authorities.
The DIDARP team represents a subset of the larger PDA/M Working Group. In fact, they are
funded to create research infrastructure for this topic, while executing the three projects
mentioned above. To nurture collaborative interprofessional research, the ETSU-DIDARP
research team has conducted fortnightly research team meetings since beginning in 2013. All
investigators, graduate students, fellows, and project staff attend each meeting. During these
meetings project/programmatic discussions enhance scientific knowledge and application by
linking relevant research information to the practical issues faced by the research team. By
sharing project updates and discussing any project-specific issues in real-time with the entire
team, the team attempts to mitigate isolation while strengthening the cohesiveness of the research
team, addressing an Interprofessional Education Collaborative (IPEC) competency in a practical
and hands-on manner (Interprofessional Education Collaborative Expert Panel, 2011). These
discussions provide opportunity for all team members to develop a common knowledge base,
generate research ideas, and collaborate across disciplines, thereby stimulating innovative
thinking regarding both substance abuse and PDA/M in the Appalachian region.
In June of 2014, Drs. Nick Hagemeier and Ivy Click received funding from the TN Department
of Health to further examine Neonatal Abstinence Syndrome (NAS). For this research project,
Drs. Click and Hagemeier target four different groups: pharmacists, primary care physicians,
pain management clinic physicians and those prescribing buprenorphine, a drug commonly used
to treat opioid addiction. Hagemeier and Click are examining how physicians talk to patients
about the risks of NAS, particularly female patients who are in their childbearing years.
Since the very first proposal, the team has worked diligently on developing new ideas and
products. Their work has spawned policy analysis, evaluation activities, field placements for
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graduate students, movie nights on campus and countless new activities. A few quantifiable
measures are the number of publications, grant proposals and their interprofessional nature.
Seven PDA/M related manuscripts have been published in peer-reviewed journals during the last
four years. The manuscripts are analogous to the composition of the working group in that they
are published in journals that cross multiple disciplines.








Prescription disposal practices: A 2-year ecological study of drug drop box donations in
Appalachia. American Journal of Public Health. 2015.
Factors associated with provision of addiction treatment information by community
pharmacists. Journal of Substance Abuse Treatment. 2014.
Theoretical exploration of Tennessee community pharmacists’ perceptions regarding
opioid pain reliever abuse communication. Research in Social & Administrative
Pharmacy. 2014
Prescription drug abuse: A comparison of prescriber and pharmacist perspectives. Drug
Abuse: Substance Use & Misuse. 2013.
Prescription drug abuse and DEA-sanctioned drug take-back events: Characteristics and
outcomes in rural Appalachia. Archives of Internal Medicine. 2012.
Prescription drug abuse communication: A qualitative analysis of prescriber and
pharmacist perceptions and behaviors. Research in Social and Administrative Pharmacy.
2015.
Correlates of prescription opioid legitimacy estimations among community pharmacists
in Tennessee. Health Education and Behavior. (Under Review).

Furthermore, the team has submitted sixteen new prescription drug-related research proposals,
seven of which have been funded with one currently under review. The PDA/M Working Group
and DIDARP team also host a monthly Accreditation Council for Continuing Medical Education
(ACCME) Accredited Grand Rounds series during the academic year and present research
findings at a number of regional and national events. In total, working group members have
presented at more than 35 invited events, including presentations to legislative committees of the
Tennessee House and Senate. In 2013 the team hosted the Appalachian Regional Summit on
Prescription Drug Abuse which convened experts from across central Appalachia and included
speakers from the White House Office of National Drug Control Policy and the Drug
Enforcement Agency.
Community outreach and education efforts are central to the mission of the team and
collaborative partnerships have resulted in the development of a funded anti-drug coalition in
Carter County, TN, a regional Naloxone Training and Access task force, and a workforce
initiative aimed at engaging local business and industry in the adoption of comprehensive
prevention programs and policies. In March of 2016, the culmination of these products both
academic and collaborative resulted in formal approval for the ETSU Center for Prescription
Drug Abuse Prevention and Treatment by the Tennessee Board of Regents. A description of the
academic environment that contributed to the momentum of the PDA/M Working Group and
development of the Center follows, as components may be replicable specifically when
collaborative effort is required to address an urgent health concern.
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The Working Group has become a fertile landscape for the development of research and
implementation of evidenced-based strategies in the surrounding communities. As funding
opportunities arise, personnel are selected based on research track record, readiness for the
research effort, content expertise, and PDA/M interest. Team members must be willing to
substantively contribute to the application process and provide scientifically valid and
professional input. Students are mapped on to these studies as well, according to their area of
interest and aptitude for the subject matter.
The group maintains a website and consistently updates social media outlets to share funding
opportunities, research progress and outcomes, training opportunities, and related legislation.
The group’s website is www.etsu.edu/cph/pdam.
Institutional and Regional Research Initiatives
Interprofessional education (IPE) is at the heart of the student and faculty experience at ETSU.
The Interprofessional Education & Research Committee (IPERC) operates at the Academic
Health Sciences Center (AHSC) level and is charged with assuring a path for interprofessional
competency attainment by all AHSC graduate and professional students, a goal supported by the
AHSC Deans and the Vice President for Health Affairs. Given cultural and regional barriers to
health care, IPE is a necessity to address regional health disparities.
The ETSU-DIDARP team has built much of its work around the Appalachian Research Network
or AppNET. AppNET is a Health Services and Resources Administration (HRSA)-funded, rural
Appalachian Practice-Based Research Network (PBRN), and the framework from which we
conduct most ETSU-DIDARP projects. AppNET is housed within the ETSU College of
Medicine and currently has 20 clinic groups with approximately more than 100 physicians and
32 mid-level providers actively participating in AppNET activities. Presently, AppNET has
several research efforts that involve working with member clinics on their medication
reconciliation process to reduce adverse medication events; developing an automated clinic data
mapping system that will provide clinics with quality improvement data; and determining the
factors that are associated with the prescribing of control medications. One goal of the ETSUDIDARP project is to expand AppNET infrastructure to include community pharmacies and
local health departments in the region. This development is necessary to facilitate collaborative
project activities that would not be possible without this infrastructure. Furthermore, this
expansion maximizes the potential of past and future investments in the regional PBRN
infrastructure.
Interprofessional Stakeholders
Regional health care providers and community stakeholders have been at the forefront of a
grassroots effort to “do something” about PDA/M in Northeast Tennessee. ETSU has a rich
tradition of community-based engagement with health issues, perhaps more so when compared
to other institutions given the relatively small cities and rural culture of the area. As an example
of community support, the team has partnered with primary care clinics, pediatrics clinics, pain
management clinics, pharmacies, regional substance abuse coalitions and health departments.
The Working Group includes several clinical care providers of both abstinence-oriented and
medication-assisted substance abuse treatment.
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Importantly, one key stakeholder is the Tennessee Commissioner for Health, John Dreyzehner,
MD, MPH, a national expert on prescriber efforts to mitigate harm from PDA/M and NAS. He
was instrumental in creating legislation to mandate prescriber and pharmacist use of the
Tennessee Controlled Substance Monitoring Database (CSMD). The law, signed by the
Governor in April 2012, took effect in January 2013. Commissioner Dreyzehner was also
instrumental in helping Governor Bill Haslam to develop a 25-point State of Tennessee strategy
to reduce PDA/M and is responsible for implementing more than half of the items on the plan.
Dr. Dreyzehner is on the External Advisory Board of the DIDARP Program and consults with
the leadership of the PDA/M Working Group team as needed.
ETSU students are similarly invested and interested in PDA/M research. Many have not only
been exposed to PDA/M problems in classroom settings, they or their families have lived it.
Students have lost loved ones to prescription drug overdoses, become addicted to prescription
drugs themselves, or have experienced the community-level impact of PDA/M. Graduate and
professional students are conducting PDA/M research with ETSU-DIDARP personnel and many
are taking their knowledge to the regional communities. As an example, Gatton College of
Pharmacy and Quillen College of Medicine students established a Generation Rx team that
makes PDA/M presentations to local high school and junior high students. To date, the
Generation Rx group, under the direction of Dr. Sarah Melton, has reached over 2,000 students.
This group has also developed an AHSC-supported provider toolkit specific to PDA/M. Within
the College of Pharmacy, over 40 future pharmacists (nearly 20% of eligible students) are
choosing to take research electives every semester; several of which are related to substance
abuse. One of the team members has shared her mother’s story of painkiller addiction on
National Public Radio and frequently tours with her mother, a recovering pain medication addict,
to educate the public. Finally, it should be noted that several students in public health are
working with the authors of this work on PDA/M topics for their dissertation or capstone
projects.
In order to foster continued professional development, faculty, students and staff are invited to
participate in multidisciplinary PDA/M Journal Club and ACCME Accredited Grand Rounds
activities on a monthly basis. These events expose members of the team to multidisciplinary
research projects that have been conducted and published by research peers across the country,
which allows for cross-pollination between research disciplines and encourages innovative
discussions regarding substance abuse/misuse in the Appalachian region. These sessions are
expected to enrich both current and future research within the AHSC.
The PDA/M Working Group and the ETSU-DIDARP team have established a milieu for
successful conduct of research on campus via its meeting, grand rounds and journal club efforts.
The team has also engaged in several measures to increase interprofessional research capacity on
campus. Below, two examples of that capacity are offered: the faculty development series and
the detailed student assessment.
Faculty Development for Interprofessional PDA/M Research
Academic and continuing educational coursework is fundamental for the faculty who are
formally participating in the program as investigators or staff. Options for training depend on the
course of study for the students and the specific learning objectives for the faculty. A set of
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courses and training activities was established for the faculty and students enrolled in the
program. Current and to-be-developed courses used by the team for training of the participants
are found in Table 1. The Working Group will participate in the development of additional
courses based on research competency needs.
Table 1. Courses and Training available for Faculty and Students
Course:

Description:

Resource:

Risk Behavior
Epidemiology

An introduction to the epidemiology of risk behaviors and
EPID course
the application of risk behavior research including
number to be
concepts/theory of health/risk behavior, major risk behaviors, determined
determinants of risk behaviors, risk behavior and the health
care delivery system, and the future of risk behavior
research.

Grant Writing

Instruction in grant writing, including the development of a
long-term research agenda, the identification of funding
sources for research, advance planning for grant proposals,
and an introduction to writing grant proposals. Emphasizes
refinement of writing skills, development of an
organizational vision, budget development, and budget
justification, goal-setting and political realities.

Faculty:
GRAD 7820
& GRAD
7830

Evidence-Based
Public Health

Provides skills for using best practices and other evidencebased methods as components of a systematic approach to
finding effective interventions to community health
challenges in diverse populations.

COBH 6250

Communication
Theory

Examines the study of traditional, modern, and emerging
communication theories as analytical tools to understand
how communication operates in a variety of settings.

SPCH 5330

Students:
ELPA 6955

Interdisciplinary An introduction to the nature and value of interdisciplinary
study. Literature, scientific theory, critical theory, and/or
Research
social science, historical, and philosophical constructs may
be brought to bear on the study of interdisciplinarity.

MALS 5100

A basic understanding of alcohol and drug abuse. Various
classifications of drugs, specific abuse symptomatology,
specific causes of drug abuse, characteristics of high-risk
groups, various treatment models, preventative efforts, and
regulations controlling the use of drugs in society are
examined.

SOWK 5367

Alcohol and
Drug Abuse

Published by Digital Commons @ East Tennessee State University, 2016

7

International Journal of Health Sciences Education, Vol. 3 [2016], Iss. 2, Art. 5

Substance
Abuse and
Addiction in
Appalachia

An integrated study of the history, physical, sociocultural,
and psychological effects of substance abuse and the
underlying disease of addiction. Place and social
determinants of health are explored as causes of addition in
Appalachia. Expert panelists are used.

PMPR 7118

Non-Medicinal
Drug Use

Topics centered around the use of drugs for non-medicinal
purposes, discussion on the continuum of legitimate versus
non-legitimate drug use, or medical versus non-medical use.
The major focus of the subject material pertains to issues of
drug abuse, particularly in Appalachia and other rural
environments.

PMSC 7203

Student Development for Interprofessional PDA/M Research
Students are integral to the success of the research program as the team strives to develop a cadre
of experts to carry on PDA/M research. The team is intentional in creating an environment that
engages students from diverse backgrounds in regional PDA/M prevention efforts, creates
interest in PDA/M research careers, and provides mentoring that is fruitful and constructive.
Undergraduate student development consists primarily of research shadowing and volunteer
opportunities with project researchers and staff. Undergraduate students are paired with graduate
students conducting PDA/M research activities, forming a mentor/protégé relationship. Dr.
Hagemeier participated in the development and implementation of a graduate student/prepharmacy student mentor/mentee program during his graduate education (Kiersma et al., 2012),
and a similar process is employed at ETSU to expose undergraduate students to research through
informal mentoring activities. At the discretion of ETSU-DIDARP faculty members,
undergraduate students may be given additional research responsibilities (e.g., data entry and
analysis and research proposal development).
Graduate students and fellows are essential members of the research team and actively
participate in team meetings and monthly PDA/M Working Group meetings. Their development
plan is based on core research competencies promulgated by the National Postdoctoral
Association (NPA). NPA competencies include:
1) discipline-specific conceptual knowledge;
2) research skill development;
3) communication skill development;
4) professionalism;
5) leadership and management skill development; and
6) responsible conduct of research (National Postdoctoral Association Core
Competencies Committee, 2009).
Development activities can be divided into three core areas: graduate-level coursework,
mentoring, and experiences gained through active participation in team research. Students serve
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as research assistants for the program, spending on average 80 hours monthly gaining hands-on
PDA/M research experience. Graduate students routinely present journal club articles to the team
and solicit input from team members regarding proposed graduate student research projects.
Mentoring takes place at the advisor level as well as at the project team level. The strong
collaborative relationships within the project team and PDA/M Working Group promote
interdisciplinary mentoring relationships. For example, College of Public Health graduate
students have developed mentor/protégée relationships with College of Medicine and College of
Pharmacy faculty members. Doctor of Pharmacy (PharmD) students develop PDA/M research
skills through participation in research electives with program faculty members. Dual-degree
(MD/MPH, PharmD/MPH) students participate in DIDARP activities through completion of
research electives or through extracurricular participation in research activities as deemed
appropriate by team researchers. Professional student experiences include mentor-guided
research training.
The ETSU-DIDARP Program provides funding for Community Pharmacy Research Fellows.
The fellows’ development is similar to graduate training in the College of Public Health and is
designed to provide a strong foundation in research skills development. In addition to graduatelevel coursework and participation in program research activities, the fellows focus on applying
PDA/M research concepts in pharmacy practice settings. Fellows actively participate in research
team and PDA/M Working Group meetings, enroll in the MPH program and complete activities
and coursework as described below. Presentation of team project research at national meetings is
an expectation of fellows.
The rubric for the formative DIDARP was developed from the NPA core competencies, and is
utilized to assess graduate student research skill development annually. Students self-assess their
progress and external assessments are conducted by primary research advisors. The ETSUDIDARP program represents a model for mentoring that is frequent, nurturing, consistent and
focused on academic products.
Congruent with the theme of mentoring, the team supports internal peer review for manuscripts
and grant proposals. Internal peer review serves to increase competitiveness of proposals and
papers that are reviewed. Planning for the process in terms of time forces the principal
investigator to prepare early and give them time to make corrections when pointed out by peer
reviewers. Sophisticated research universities regularly peer review their products before
submission and this infrastructure is crucial to develop at our university.
Infrastructure Development for Interprofessional PDA/M Research
As a historically strong health sciences teaching university with deep roots in clinical care,
community partnerships and rural health, the infrastructure for research activities has been a
second priority, until recently. In order to compete at the national level for research funding,
several issues can be addressed alongside this interprofessional PDA/M prevention effort.
It is important that the university develops research infrastructure to support long-term strategic
initiatives to improve health. The formation of interprofessional research centers is an essential
step in the framework of research development. Prior to the establishment of the Center for
Prescription Drug Abuse Prevention and Treatment the university had only one research center
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for health. ETSU recently celebrated its 100th anniversary and shortly thereafter began the
visioning process for 2037 through establishment of the Committee for 125 (www.etsu.edu/125).
One of the subcommittees developed a plan for research growth as one of the greatest
opportunities and necessities for the university in the coming quarter century.
In 2013, the ETSU president formed an ad-hoc committee to develop a strategic plan to grow
research at the university. The recommendations are consistent with the visioning for 125.
Interprofessional research is a cornerstone of the plan.
Discussion
The overarching goal of the newly established Center for Prescription Drug Abuse Prevention
and Treatment is to strengthen research infrastructure and foster research career development on
multiple levels. Accomplishment of these goals will establish multiple lines of PDA/M-related
research. The results of this work could transform the career paths of many of our junior faculty
and undergraduate, professional, and graduate students. Moreover, with high quality, nationally
competitive research being conducted at ETSU that is focused on PDA/M, the team has the
potential to bend the curve on the problem, beginning in the region and impacting the work in the
state and nation.
We feel strongly that ETSU should be one of the major hubs for prescription drug abuse research
in Appalachia. We aim for our work to attract additional researchers to ETSU and therefore
positively impact the number and quality of researchers focused on the topic. Our local substance
abuse prevention coalitions are strong partners of the team and we anticipate increased
collaboration with state and regional substance abuse coalitions, Tennessee’s Controlled
Substance Monitoring Database Advisory Council, Tennessee Department of Health, and other
regional stakeholders.
Conclusion
The AHSC at East Tennessee State University has a highly trained, interprofessional faculty that
serves the region and is committed to combating prescription drug abuse and misuse in
Appalachia. PDA/M is a national problem and one for which control measures are urgently
needed. The collective impact that has been achieved by bringing together scholars and
community leaders in a collaborative and supportive institutional environment can be replicated.
Center staff are currently engaged in establishing a formal partnership with Mountain States
Health Alliance, a regional health care system, to create a comprehensive, not for profit, opioid
treatment program that will ultimately help fund Center prevention initiatives across the region.
This clinical component of the newly established Center will also allow for ongoing research to
support continued infrastructure development and attract extramural funding. Looking forward,
the team plans to convene interested universities across central Appalachia to begin a
conversation about how we might work together on a systematic and concerted plan to address
this problem at each point along the continuum of disease.
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